Authors
Latest:
Combating the ‘Talent Wars’ in BiopharmaCompetency-based and other creative approaches are needed to address the battle for talent in the clinical research workforce.
Latest:
Winning the Competition for Clinical Sites By Reducing Site User BurdenWith the number of clinical trials and sponsors increasing every year, meeting enrollment requirements and timelines becomes harder and harder. Please join Almac Clinical Technologies and Exostar as they discuss solutions to attract and retain the right resources to meet your requirements and timelines. Live: Thursday, Aug. 27, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Aug. 27, 2021.
Latest:
Reducing Patient Dropout Rates and Accelerating Trial CompletionJon Ernst (Vice President, In-Home Solutions, Decentralized Clinical Trials) discusses today's clinical trial landscape.
Latest:
The Impact of ICH E6(R3) on Biospecimen ManagementWebinar Date/Time: This event is available on demand
Latest:
Harmonizing Outsourcing to Keep Clinical Trials on TrackA shared partnership culture is critical in navigating today’s complex terrain.
Latest:
Navigating the Future of Decentralized Clinical TrialsAlthough executive enthusiasm for decentralization of clinical trials has grown significantly, operationalizing these models requires meticulous planning and risk-based quality management.
Latest:
Modernizing Patient-Reported Outcomes: Bridging the Gap Between Legacy Measures and Contemporary HealthcareStrategies for ensuring that innovation with PROs remains parallel with advancements in disease detection and progression.
Latest:
A Market Failure for Antimicrobial Resistant MedicinesWhile the world focuses on COVID-19, this article provides insight on the current state of the market for antimicrobial resistant (AMR) medicines.
Latest:
Challenges in Conducting Multicentric Infectious Giardia Diarrhea Clinical Studies in IndiaMulticentric studies on diarrhea are essential for comprehending its epidemiology, causes, and treatment outcomes.
Latest:
Oncolytic Virus Immunotherapy: A Brief Overview and Considerations for Clinical Trial PlanningSuccessful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
Latest:
Clinical Trial Matching Solutions: Understanding the LandscapeA framework to understand the different approaches of trial matching solutions and the major operational and workflow challenges that all matching solutions share.
Latest:
REDEFINE 1 Trial Finds Cagrilintide–Semaglutide Combo Delivers Over 20% Weight Loss in Majority of PatientsOnce-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits, according to Phase IIIa trial results published in The New England Journal of Medicine.
Latest:
Workforce Trends in Drug DevelopmentTufts CSDD study breaks down state of the talent pipeline from lens of senior leaders.
Latest:
Accelerate Inclusive Enrollment and Delivery with LightshipDavid MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.
Latest:
De-Risking Trials with Science-Driven OversightIdentifying the ‘significant six’ areas of clinical study conduct to mitigate risk.
Latest:
When Should the Audit Trail Begin?A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.
Latest:
R&D Using the Metaverse and Digital TwinsHow the digital environment can transform drug development space.
Latest:
Optimizing Phase III Oncology Trial Recruitment with Data-Driven InsightsA pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
Latest:
Enhancing Empowerment in Patient-Focused ResearchHow the inclusion of measures centered on net treatment benefit can drive an effective multifaceted approach.
Latest:
Tailored Patient Involvement in Clinical TrialsThe approach of the Cancer Research UK Centre for Drug Development.
Latest:
Why and How to Infuse Methodological Rigor into Psychedelic Clinical TrialsRenewed interest in psychedelic research shows great promise for patients in need of more effective therapies.
Latest:
Transforming Healthcare DataWe are amidst a data revolution in healthcare and the life sciences. With advances in DNA sequencing, multiomics, wearables, imaging, and clinical data capture, there is more data — and there are more data modalities — to draw from for biomedical research than ever before. However, the quantity, variance and speed of data generation outpaces researchers’ ability to effectively utilize it to reveal medical breakthroughs for those in need. The ability to analyze health data is critical in developing a precision health approach. By leveraging diverse data sources, researchers can determine the most effective actions for individuals and communities. However, current barriers to data access and collaboration hinder progress. To accelerate the pace of discovery, a solution is needed to close the gap between research and health care. This paper describes how Verily Workbench provides solutions for healthcare professionals and researchers to easily access and collaborate on data within an integrated analysis and governance framework. Workbench provides a community of researchers with the platform, data, and tools to solve the most pressing scientific challenge
Latest:
An Examination of the Use of Patient Recruitment and Retention Tactics for Global StudiesIn light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.
Latest:
Patient-Tested Practices for In-Home TrialsBringing clinical trials to patients’ homes can address existing site-based challenges.
Latest:
The Powerful Impact of Caregivers on Clinical TrialsConsidering caregiver-supported trials to improve patient retention and outcomes.
Latest:
How Clinical Trial Research Sites Can Gain Access to a More Level Playing FieldTo overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.
Latest:
The Eradication of False Signals in MonitoringHow optimizing RBQM risk detection reduces the efforts caused by false signals.
Latest:
Managing Clinical Trial AgreementsHow Clinical Research Malaysia sped up CTA turnaround using a web-based system.
